Navigation Links
MDS Appoints Two New Directors
Date:4/21/2008

Gregory Spivy and William Dempsey join MDS Board

TORONTO, April 21 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, today announced that Mr. Gregory Spivy, Partner at ValueAct Capital, and Mr. William Dempsey, former Executive Vice-President of Abbott Laboratories, have been appointed to its Board of Directors.

"We welcome both Greg and Bill and look forward to benefiting from the breadth of experience they will bring to our Board," said John Mayberry, Chairman, MDS Board of Directors. "The decision of both individuals to join the Board follows months of discussion and is consistent with our objective to strengthen and broaden the Board's expertise."

Mr. Mayberry continued, "Greg adds the perspective of a major shareholder with financial markets expertise, along with the knowledge and experience of having served on the boards of other publicly traded companies. Bill is an industry veteran and possesses the operational skills, knowledge and perspective of our customers that come from more than 25 years of pharmaceutical industry experience. We believe that the capabilities of both individuals will be additive and prove valuable to the Board as we continue to execute on our strategy to deliver value to all of our shareholders."

"MDS has built a strong position in the global life science markets and has developed a solid foundation upon which to generate sustainable and profitable growth," stated Mr. Spivy. "I believe there is growth potential in the MDS markets and I look forward to working actively with my fellow directors and MDS's management team to capitalize on these opportunities."

"I am pleased to be joining the MDS Board of Directors," stated Mr. Dempsey. "This is an excellent company with a history of innovation, quality products and services, and a leadership team driving performance."

Mr. Spivy is a Partner at V
'/>"/>

SOURCE MDS Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. MaxLife Fund Corp. Appoints Mr. Dan Schmitt, Mr. Randy Delkus and Mr. Daniel E. Kahan to its Board of Directors
2. Bioniche Appoints U.S. President of Food Safety
3. WellPoint Appoints Kevin R. Hayden as President of State Sponsored Business
4. LodgeNet Appoints John E. Haire, Former Time Warner Executive, to Board of Directors
5. ProGenTech Limited Appoints Executive Management Team
6. Precyse Solutions Appoints Karen Heisler as New Corporate Vice President, Human Resources
7. Kendle Promotes Simon S. Higginbotham to President; Appoints Alan J. Boyce as Chief Marketing Officer
8. Optimal Readings Appoints Operations Veteran Rita Edwards as SVP Clinical Operations
9. Stiefel Laboratories Appoints First Chief Scientific Officer
10. Stereotaxis Appoints Senior Vice President of Global Marketing and General Manager for Europe
11. Prevent Child Abuse Georgia Appoints New CEO

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...rMadeinSupportofFeedingAmerica,sSNAPOutreachEffort...edingAmerica,thenation,slargesthunger-relieforgani...ofAmericaCharitableFoundationtosupportFeedingAmeri...lementalNutritionAssistanceProgram(SNAP),formerlyn...edingAmericafoodbanksimproveaccessandprovidepre-sc...
(Date:11/25/2009)... essential to normal human development - the Wnt/W... (EGFR) pathways - interact in ways that can promo... from The University of Texas M. D. Anderson Cance... Cell . , This newly characterized interaction i...ate with invasive cancer - activation of EGFR, ele...
(Date:11/25/2009)...n R. Kaplan, MD, FACP, a former Board Chair and on...ecame Los Angeles Biomedical Research Institute at...onored by the American College of Physicians for h...At its April 22, 2010 meeting in Toronto, the Amer... with the Ralph O. Claypoole Sr. Memorial Award fo...
(Date:11/25/2009)...at UT Southwestern Medical Center soon will begin ...ing in patients with upper spinal-cord injuries or...pendently. , UT Southwestern University Hospita... and one of 25 in the country currently equipped t...acing System. , The device is designed to give p...
(Date:11/25/2009)...ial function plays in insulin production , ...ondrial damage causes people with type 2 diabetes ...uld lead to new treatments, U.S. researchers say. ...vity. , The researchers found that when insulin...d to circulating insulin, it triggers a "molecular...
Breaking Medicine News(10 mins):Health News:Bank of America Charitable Foundation Presents $1 Million Contribution to Feeding America in an Effort to Help Connect Low-Income Americans With Federal Nutrition Programs 2Health News:Bank of America Charitable Foundation Presents $1 Million Contribution to Feeding America in an Effort to Help Connect Low-Income Americans With Federal Nutrition Programs 3Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 3Health News:1 of LA BioMed's founders to be honored 2Health News:New device implanted by surgeons help paralyzed patients breathe easier 2
...ld Allow Condom Distribution in CA Correctional,Fa...lifornia HIV Advocacy Coalition (SCHAC) and the Ca... on Tuesday, October 2, at 10:00 a.m. (in front,of...y Act" (Swanson, D, Oakland), which will help redu...
...stored normal blood pressure, study finds , ...n study has identified overweight as a direct caus...up to half of overweight people can bring down blo... Dr. Roberto Fogari, professor of medicine at the ...
...to warn Americans about risks of indoor tanning de...rtant step,which may help reduce significantly the...Bush yesterday signed the Tanning Accountability a... directs the U.S. Food and Drug Administration (FD...
...as An inflammatory eye condition that is one of t...ated much more effectively and easily thanks to a ...ory rats, scientists at the University of Texas Me... outer surface of the eyeball and includes the iri...
... be Cut; Plan Changes Will Reduce Cost Increases b... HARRISBURG, Pa., Sept. 28 The Office of,Administ... Retired,Employees Health Program (REHP) that will...challenges facing,employers across the country," S...
...2007 (Aliso Viejo, CA) Ossur, a trusted and globa...etic innovations than any other company in the fie...s the winner of a 2007 da Vinci Award. , The PR...lectronics, mechanics, and human physiology that r...
Other Medicine News:Health News:Community Leaders to Host Press Event at L.A. Central Jail Urging Governor to Sign AB 1334 2Health News:Weight Loss Can Control Hypertension 2Health News:Weight Loss Can Control Hypertension 3Health News:American Academy of Dermatology Association Commends President Bush for Signing Tanning Accountability and Notification (TAN) Act 2Health News:New discovery may improve treatment of one of the world's leading causes of blindness 2Health News:Office of Administration Announces Plan to Preserve Health Care Benefits for Current, Future Retired Commonwealth Employees 2Health News:Office of Administration Announces Plan to Preserve Health Care Benefits for Current, Future Retired Commonwealth Employees 3Health News:Office of Administration Announces Plan to Preserve Health Care Benefits for Current, Future Retired Commonwealth Employees 4Health News:Office of Administration Announces Plan to Preserve Health Care Benefits for Current, Future Retired Commonwealth Employees 5Health News:Office of Administration Announces Plan to Preserve Health Care Benefits for Current, Future Retired Commonwealth Employees 6Health News:Office of Administration Announces Plan to Preserve Health Care Benefits for Current, Future Retired Commonwealth Employees 7Health News:Ossur's Proprio Foot nets the 2007 da Vinci Award 2
(Date:11/24/2009)...a/--ChindexInternational,Inc.,("Chindex")(Nasdaq: ...n,healthcareproductsandservicesinthePeople,sRepubl...he21stAnnualPiperJaffray,"Unplugged"HealthCareConf...eHotel. , Managementiscurrentlyscheduledtopre...e-on-onemeetingsthroughouttheday.Awebcast,ofthepre...
(Date:11/24/2009)...ll/--AnadysPharmaceuticals,Inc.(Nasdaq: ANDS )anno...frayHealthcareConferenceonTuesday,December1,2009at...tTheNewYorkPalaceHotel.SteveWorland,Ph.D.,Presiden...rviewofAnadysanditsclinicaldevelopmentprograms,ANA...simultaneouslywebcastandcanbeaccessedontheInvestor...
(Date:11/24/2009)...-ZargisMedicalCorp.,asubsidiaryofSpeedusCorp.(Nasd...(NYSE: SI ),todayannouncedthatitsZargisCardioscand...TheEarlyShow duringasegmentinwhichMarkJannot,theed...productsfromthepublication,s2009"BestofWhat,sNew"a...ionmorningnewstalkshowbroadcastbyCBSfromNewYorkCit...
Breaking Medicine Technology:Chindex International to Present at Piper Jaffray Health Care Conference 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 3Cystic Fibrosis Treatment May Cause Hearing Loss 50673 1Cardinal Health Appoints Bruce Downey to Board of Directors 3B John McCoy Retires From Board After 22 Years 50670 1Cardinal Health Appoints Bruce Downey to Board of Directors 3B John McCoy Retires From Board After 22 Years 50670 2CyberGlove Systems Hosts Worldwide Contest for New Motion Capture Technology Applications 50667 1CyberGlove Systems Hosts Worldwide Contest for New Motion Capture Technology Applications 50667 2CyberGlove Systems Hosts Worldwide Contest for New Motion Capture Technology Applications 50667 3
...mmary: Proprietary DNA delivery technology enables...cells - reduces,atherosclerosis progression in mou...WIRE)--Mar 26, 2007 - Research conducted,at Clevel...lege of,Cardiology,s 58th Annual Scientific Sessio...ing the anti-inflammatory protein,interferon-beta ...
...ISIS 301012 coadministered with statins for only f...the levels achieved with,statins alone, with simil..., NEW ORLEANS and CARLSBAD, Calif., March 26, 2007...nc. announced new,results from its Phase 2 clinica... presented today at the of Cardiology,Annual Scien...
Other Medicine Technology:Interferon Beta DNA Treatment Delivered with Ichor Technology,Reduces Atherosclerosis Progression in Mice 2Interferon Beta DNA Treatment Delivered with Ichor Technology,Reduces Atherosclerosis Progression in Mice 3Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 2Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 3Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 4Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 5Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 6Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 7Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 8Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 9
Full Handle Laseredge Implant Blade Knife, 3.2 mm round tip
Full Handle Laseredge Implant Blade Knife, 5.2 mm angled bevel up
Full Handle Laseredge Implant Blade Knife, 4.0 mm angled bevel up
Full Handle Laseredge Crescent Blade Knife, angled bevel down
Medicine Products: